PLASMEX
Live / Registered — International registration cancelled — extension of protection cancelled (as of 02 Jul 2020)
What this means for you
Registered since 24 Jan 2012. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79085223
- Registration number
- 4089467
- Mark type
- Stylized text
- Filed
- 02 Jul 2010
- Published for opposition
- 08 Nov 2011
- Registered
- 24 Jan 2012
- Attorney of record
- Stacey R. Halpern
Goods and services
- Class 001 — Chemicals: Chemical reagents not for medical or veterinary purposes; protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicals, namely, polypeptides for in vitro and in vivo scientific and research use; biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research use; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific research, reagents, cosmetics, and pharmaceuticals
- Class 005 — Pharmaceuticals: Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancer, critical limb ischemia, cystic fibrosis, retinitis pigmentosa, AIDS, influenza, and Alzheimer's disease; preparations for gene therapy, namely, introducing genes to human and animal cells, tissues, organs and living bodies, and growth media for medical purposes; vaccines; gene vaccines; vectors for introducing genes to human and animal cells, tissues, organs and living bodies, and growth media for medical use, namely, for gene therapy
- Class 042 — Scientific and technological services: Testing, inspection, research, or development of pharmaceuticals, cosmetics, or foodstuff; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing, inspection, research, or development of vaccines; testing, inspection, research, or development of recombinant proteins; medical, chemical, biochemical, biological and bacteriological research and functional analysis of genes or proteins; testing, inspection, or research related to technologies for manufacturing genetically engineered animals, plants, and vectors; testing, inspection, research, or development of vector technologies, namely, medical and scientific research in the field of genetics and genetic engineering; testing, inspection, or research on agriculture, livestock breeding, or fisheries; testing, inspection, research, or development of chemicals for life science; testing or research on machines and instruments; computer software design, computer programming, or maintenance of computer software; rental of computers or providing computer programs
Owner
- ID Pharma Co., Ltd., JP
- DNAVEC CORPORATION, JP
- DNAVEC CORPORATION, JP
Prosecution history
- 23 Jul 2021 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 23 Jul 2021 — DEATH OF INTERNATIONAL REGISTRATION
- 26 Jul 2019 — TOTAL INVALIDATION PROCESSED BY THE IB
- 23 May 2019 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 23 May 2019 — INVALIDATION PROCESSED
- 30 Apr 2019 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 31 Aug 2018 — CANCELLED SECTION 71
- 24 Jan 2017 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 01 Oct 2015 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 08 Sept 2012 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Aug 2012 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Aug 2012 — FINAL DISPOSITION PROCESSED
- 24 Apr 2012 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 24 Jan 2012 — REGISTERED-PRINCIPAL REGISTER
- 06 Jan 2012 — NOTIFICATION PROCESSED BY IB